NASDAQ · SABS
SAB Biotherapeutics, Inc.
Healthcare · Biotechnology
$3.23
Up+$0.03 (+0.94%)
Updated Oct 30, 2026, 9:07 AM
SID Score
2.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 34.31M
- P/E ratio
- 2.04
- Dividend yield
- 0.00%
- 52-week range
- $2.44 – $5.15
- Volume
- 458.27K
- Avg. volume
- 331K
Price performance · SABS
SABS price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 29, 2026
SABS closed at $3.23 after 21 trading sessions, up 5.56% for the selected period.
- Last close
- $3.23
- Period change
- +5.56%
- Period low
- $2.49
- Period high
- $3.23
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | $3.23 | $3.36 | $3.16 | $3.23 | 458.27K |
| Oct 28, 2026 | $3.04 | $3.22 | $3.01 | $3.20 | 347.83K |
| Oct 27, 2026 | $2.80 | $3.09 | $2.80 | $3.07 | 646.57K |
| Oct 26, 2026 | $2.82 | $2.94 | $2.765 | $2.79 | 324.52K |
| Oct 23, 2026 | $2.98 | $3.04 | $2.82 | $2.84 | 1.02M |
| Oct 22, 2026 | $2.83 | $3.08 | $2.83 | $3.04 | 710.22K |
| Oct 21, 2026 | $2.88 | $2.99 | $2.795 | $2.82 | 388.77K |
| Oct 20, 2026 | $2.59 | $2.93 | $2.5537 | $2.88 | 814.54K |
| Oct 19, 2026 | $2.53 | $2.645 | $2.44 | $2.60 | 602.33K |
| Oct 16, 2026 | $2.59 | $2.63 | $2.47 | $2.53 | 756.99K |
| Oct 15, 2026 | $2.51 | $2.6197 | $2.48 | $2.59 | 787.94K |
| Oct 14, 2026 | $2.64 | $2.72 | $2.45 | $2.49 | 853.18K |
| Oct 13, 2026 | $2.84 | $2.875 | $2.615 | $2.68 | 893.5K |
| Oct 12, 2026 | $2.99 | $3.00 | $2.80 | $2.83 | 359.06K |
| Oct 9, 2026 | $2.905 | $3.02 | $2.81 | $2.98 | 659.61K |
| Oct 8, 2026 | $2.85 | $2.93 | $2.76 | $2.89 | 1.14M |
| Oct 7, 2026 | $2.90 | $2.965 | $2.81 | $2.88 | 681.68K |
| Oct 6, 2026 | $3.12 | $3.16 | $2.915 | $2.93 | 663.65K |
| Oct 5, 2026 | $3.00 | $3.25 | $2.855 | $3.10 | 866.27K |
| Oct 2, 2026 | $3.10 | $3.12 | $2.96 | $2.98 | 416.32K |
| Oct 1, 2026 | $3.15 | $3.225 | $3.04 | $3.06 | 426.59K |
Latest SABS news
The latest Smart Investors Daily articles mentioning SABS.
Stock researchMarket Activity · Options
Company
Market Activity
Research & News

